Tensin4 is upregulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinoma

Oncotarget

Volumn 6, Issue 25, 2015, Pages 20964-20976

  Chan, Lo Kong ^a   Chiu, Yung Tuen ^a   Sze, Karen Man Fong ^a   Ng, Irene Oi Lin ^a  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cten; EGF; ERK1 2 activity; HCC

Indexed keywords

EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RAS PROTEIN; TENSIN; TENSIN4; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; TNS4 PROTEIN, HUMAN;

ACTIN FILAMENT; ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOCAL ADHESION; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER CELL CARCINOMA; MALE; PROTEIN DOMAIN; PROTEIN EXPRESSION; SH2 DOMAIN; UPREGULATION; CELL MOTION; CHEMISTRY; CYTOLOGY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LIVER TUMOR; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; TUMOR CELL LINE;

ACTIN CYTOSKELETON; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; FEMALE; FOCAL ADHESIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STROMAL CELLS; MICROFILAMENT PROTEINS; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; TENSINS; UP-REGULATION;

EID: 84940765539     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4122     Document Type: Article

References (30)

1. Lo SH. Tensin. Int J Biochem Cell Biol. 2004; 36:31-34.
2. Kawai K, Iwamae Y, Yamaga M, Kiyota M, Ishii H, Hirata H, Homma Y and Yagisawa H. Focal adhesion-localization of START-GAP1/DLC1 is essential for cell motility and morphology. Genes Cells. 2009; 14:227-241.
3. Holeiter G, Heering J, Erlmann P, Schmid S, Jahne R and Olayioye MA. Deleted in liver cancer 1 controls cell migration through a Dia1-dependent signaling pathway. Cancer Res. 2008; 68:8743-8751.
4. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG and Frame MC. The role of focal-adhesion kinase in cancer-a new therapeutic opportunity. Nat Rev Cancer. 2005; 5:505-515.
5. Tlsty TD. Cell-adhesion-dependent influences on genomic instability and carcinogenesis. Curr Opin Cell Biol. 1998; 10:647-653.
6. Weisberg E, Sattler M, Ewaniuk DS and Salgia R. Role of focal adhesion proteins in signal transduction and oncogenesis. Crit Rev Oncog. 1997; 8:343-358.
7. Yam JW, Tse EY and Ng IO. Role and significance of focal adhesion proteins in hepatocellular carcinoma. J Gastroenterol Hepatol. 2009; 24:520-530.
8. Chan LK, Ko FC, Ng IO and Yam JW. Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function. PLoS One. 2009; 4:e5572.
9. Yam JW, Ko FC, Chan CY, Jin DY and Ng IO. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression. Cancer Res. 2006; 66:8367-8372.
10. Calderwood DA, Fujioka Y, de Pereda JM, Garcia-Alvarez B, Nakamoto T, Margolis B, McGlade CJ, Liddington RC and Ginsberg MH. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc Natl Acad Sci U S A. 2003; 100:2272-2277.
11. Qian X, Li G, Vass WC, Papageorge A, Walker RC, Asnaghi L, Steinbach PJ, Tosato G, Hunter K and Lowy DR. The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis. Cancer Cell. 2009; 16:246-258.
12. Martuszewska D, Ljungberg B, Johansson M, Landberg G, Oslakovic C, Dahlback B and Hafizi S. Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancer. PLoS One. 2009; 4:e4350.
13. Lo SH and Lo TB. Cten, a COOH-terminal tensin-like protein with prostate restricted expression, is down-regulated in prostate cancer. Cancer Res. 2002; 62:4217-4221.
14. Liao YC, Si L, deVere White RW and Lo SH. The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1. J Cell Biol. 2007; 176:43-49.
15. Liao YC, Chen NT, Shih YP, Dong Y and Lo SH. Up-regulation of C-terminal tensin-like molecule promotes the tumorigenicity of colon cancer through beta-catenin. Cancer Res. 2009; 69:4563-4566.
16. Albasri A, Seth R, Jackson D, Benhasouna A, Crook S, Nateri AS, Chapman R and Ilyas M. C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer. J Pathol. 2009; 218:57-65.
17. Katz M, Amit I, Citri A, Shay T, Carvalho S, Lavi S, Milanezi F, Lyass L, Amariglio N, Jacob-Hirsch J, Ben-Chetrit N, Tarcic G, Lindzen M, Avraham R, Liao YC, Trusk P, et al. A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration. Nat Cell Biol. 2007; 9:961-969.
18. Albasri A, Aleskandarany M, Benhasouna A, Powe DG, Ellis IO, Ilyas M and Green AR. CTEN (C-terminal tensin-like), a novel oncogene overexpressed in invasive breast carcinoma of poor prognosis. Breast Cancer Res Treat. 2011; 126:47-54.
19. Sakashita K, Mimori K, Tanaka F, Kamohara Y, Inoue H, Sawada T, Hirakawa K and Mori M. Prognostic relevance of Tensin4 expression in human gastric cancer. Ann Surg Oncol. 2008; 15:2606-2613.
20. Li Y, Mizokami A, Izumi K, Narimoto K, Shima T, Zhang J, Dai J, Keller ET and Namiki M. CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancer. Prostate. 2009.
21. Cao X, Voss C, Zhao B, Kaneko T and Li SS. Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation. Proc Natl Acad Sci U S A. 2012; 109:1455-1460.
22. Brown JJ, Parashar B, Moshage H, Tanaka KE, Engelhardt D, Rabbani E, Roy-Chowdhury N and Roy-Chowdhury J. A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice. Hepatology. 2000; 31:173-181.
23. Albasri A, Al-Ghamdi S, Fadhil W, Aleskandarany M, Liao YC, Jackson D, Lobo DN, Lo SH, Kumari R, Durrant L, Watson S, Kindle KB and Ilyas M. Cten signals through integrin-linked kinase (ILK) and may promote metastasis in colorectal cancer. Oncogene. 2011; 30:2997-3002.
24. Al-Ghamdi S, Albasri A, Cachat J, Ibrahem S, Muhammad BA, Jackson D, Nateri AS, Kindle KB and Ilyas M. Cten is targeted by Kras signalling to regulate cell motility in the colon and pancreas. PLoS One. 2011; 6:e20919.
25. Sasaki H, Moriyama S, Mizuno K, Yukiue H, Konishi A, Yano M, Kaji M, Fukai I, Kiriyama M, Yamakawa Y and Fujii Y. Cten mRNA expression was correlated with tumor progression in lung cancers. Lung Cancer. 2003; 40:151-155.
26. Sasaki H, Yukiue H, Kobayashi Y, Fukai I and Fujii Y. Cten mRNA expression is correlated with tumor progression in thymoma. Tumour Biol. 2003; 24:271-274.
27. Hung SY, Shih YP, Chen M and Lo SH. Up-regulated cten by FGF2 contributes to FGF2-mediated cell migration. Mol Carcinog. 2014; 53:787-792.
28. Chen NT, Kuwabara Y, Conley C, Liao YC, Hong SY, Chen M, Shih YP, Chen HW, Hsieh F and Lo SH. Phylogenetic analysis, expression patterns, and transcriptional regulation of human CTEN gene. Gene. 2013; 520:90-97.
29. Lo SS, Lo SH and Lo SH. Cleavage of cten by caspase-3 during apoptosis. Oncogene. 2005; 24:4311-4314.
30. Chan J, Ko FC, Yeung YS, Ng IO and Yam JW. Integrin-linked kinase overexpression and its oncogenic role in promoting tumorigenicity of hepatocellular carcinoma. PLoS One. 2011; 6:e16984.